Attenuation of Helicobacter pylori-induced gastric inflammation by prior cag − strain (AM1) infection in C57BL/6 mice
© The Author(s) 2017
Received: 29 December 2016
Accepted: 28 February 2017
Published: 9 March 2017
Helicobacter pylori, colonize in stomach of ~50% of the world population. cag pathogenicity Island of H. pylori is one of the important virulent factors that attributed to gastric inflammation. Coinfection with H. pylori strain with different genetic makeup alters the degree of pathogenicity and susceptibility towards antibiotics. The present study investigates host immunomodulatory effects of H. pylori infection by both cag + strain (SS1) and cag − strain (AM1). C57BL/6 mice were infected with AM1 or SS1 strain as well as AM1 followed by SS1 (AM1/SS1) and vice versa.
Mice infected with AM1/SS1 strain exhibited less gastric inflammation and reduced proMMP9 and proMMP3 activities in gastric tissues as compared to SS1/SS1 and SS1/AM1 infected groups. The expression of both MMP9 and MMP3 followed similar trend like activity in infected tissues. Both Th1 and Th17 responses were induced by SS1 strain more profoundly than AM1 strain infection which induced solely Th1 response in spleen and gastric tissues. Moreover, IFN-γ, TNF-α, IL-1β and IL-12 were significantly downregulated in mice spleen and gastric tissues infected by AM1/SS1 compared to SS1/SS1 but not with SS1/AM1 coinfection. Surprisingly, IL-17 level was dampened significantly in AM1/SS1 compared to SS1/AM1 coinfected groups. Furthermore, number of Foxp3+ T-regulatory (Treg) cells and immunosuppressive cytokines like IL-10 and TGF-β were reduced in AM1/SS1 compared to SS1/SS1 and SS1/AM1 coinfected mice gastric tissues.
These data suggested that prior H. pylori cag − strain infection attenuated the severity of gastric pathology induced by subsequent cag + strain in C57BL/6 mice. Prior AM1 infection induced Th1 cytokine IFN-γ, which reduced the Th17 response induced by subsequent SS1 infection. The reduced gastritis in AM1/SS1-infected mice might also be due to enrichment of AM1- primed Treg cells in the gastric compartment which inhibit Th1 and Th17 responses to subsequent SS1 infection. In summary, prior infection by non-virulent H. pylori strain (AM1) causes reduction of subsequent virulent strain (SS1) infection by regulation of inflammatory cytokines and MMPs expression.
KeywordsHelicobacter pylori Cag pathogenicity island Coinfection Gastric ulcer MMP Cytokine Inflammation Immunosuppression
Helicobacter pylori, a class I carcinogen inhabit in the stomach of approximately 50% of the human population while only 10–15% population either develop chronic gastritis or gastric adenocarcinoma or gastric mucosa-associated lymphoid tissue lymphoma [1–4]. The underlying mechanisms governing the clinical outcome of H. pylori infection are poorly understood. However, accumulated evidences suggested that differences in host immune responses, environmental factors as well as the virulence properties of H. pylori strains may play important roles in determining the disease outcome. The most prominent H. pylori virulence-associated determinant is the cag pathogenicity island (PAI). It is a 40-kb genome segment that encodes the immunodominant protein cagA and type IV secretion system, which serve to transfer the bacterial cagA protein and other soluble factors such as peptidoglycans, to the cytoplasm of the host cells, known to play a key role in disease manifestation [5–7]. Strains harboring the cag PAI have been associated with more severe inflammatory responses than that induced by cag − strains [6, 8, 9]. H. pylori specific host T cell response is predominantly a CD4+ T cell response polarized towards a T helper1 (Th1) phenotype [10, 11]. H. pylori induced inflammation are associated with the production of pro-inflammatory cytokines and appear to be triggered partly by genes located within the cag PAI [6, 8, 12]. The gastric mucosal levels of the proinflammatory cytokine IL-1β, IL-6, IL-8 and TNF-α were increased in H. pylori infected subjects . Earlier studies revealed that H. pylori infection is also associated with a marked increased in cytokine IL-17 secretion from Th17 cells . Involvement of IL-17 has also been reported in various other chronic inflammatory conditions such as rheumatoid arthritis and multiple sclerosis [15, 16]. Recently, Shi et al. suggested that H. pylori infection induced a mixed Th1/Th17 response . In addition, cagA and type IV secretion system are required for the induction of IL-17 responses in H. pylori infection . Secretion of IL-17 led to induction of other inflammatory molecules required for the establishment of chronic inflammation .
MMPs are a family of zinc dependent endopeptidases that play a crucial role in various pathological conditions including gastric ulcer [20–22]. The activities of MMPs are regulated by their inhibitors (TIMPs), while their expressions are modulated by cytokines, growth factors, tumor promoters and transcription factors [20, 23, 24]. Gelatinases B (MMP9) and stromelysin-1 (MMP3) are the two major inflammatory contributors of gastric pathology, collectively cleave a large array of matrix proteins . Accumulated evidences suggested that H. pylori induced gastric inflammation with the upregulation of MMP9 and MMP3 in vivo . MMPs are either directly or indirectly produced by gastric epithelial cells via cytokine mediated cell signaling pathways .
The gastrointestinal tract of human are colonized by various microorganisms which can be either commensalistic or pathogenic to human . The interplay among those organisms can lead to either attenuation or promotion of infection-induced pathology. For instance, C57BL/6 mice coinfection with a natural murine nematode parasite Heligmosomoides polygyrus, attenuated gastric pathology induced by H. felis . Attenuation of gastric pathology was associated with reduced expression of proinflammatory Th1 cytokine as well as with increased Th2 cytokine levels. Interaction between different bacterial species also determines diseases severity. Recently it has been documented that H. pylori infection attenuated Salmonella enterica serovar Typhimurium-induced colitis in C57BL/6 mice; this protective effect was associated with downregulation of the cecal Th17 response to S. typhimurium . Even severity of the H. pylori induced gastric pathology is also modulated by coinfection with other Helicobacter species. Coinfection of enterohepatic Helicobacter species (EHS), Helicobacter muridarum along with H. pylori attenuated the H. pylori induced gastric pathology in C57BL/6 mice . Moreover, coinfection of another EHS, Helicobacter hepaticus with H. pylori lead to more severe gastritis as well as increased production of IL-17 cytokine . Interestingly, it has also been reported that the interactions between different strains of H. pylori also modulate gastric inflammation status .
Surprisingly, in some African countries having lower economic status show high rate of H. pylori infection but low level of gastric carcinoma incidence, widely known as African Enigma [32, 33]. The reasons could be associated with diet, infection with other endemic parasites and degree of pathogenicity of different H. pylori strains. We hypothesized that coinfection with a non pathogenic strain may provide protection against further infection of a virulent strain. The effect of coinfection on gastric inflammation, with different strains of H. pylori with or without cag Pathogenicity Island, has not been systematically studied yet. To investigate that, we established a coinfection in C57BL/6 mice using both cag − and cag + strains of H. pylori and measured the gastric inflammatory pathways. We address whether prior cag − strain infection alleviate gastric damage induced by cag + H. pylori strain coinfection and the underlying host immunomodulatory mechanisms thereon. Here we for the first time documents that prior infection with cag − H. pylori strain dampens the disease severity for further cag + coinfection.
Prior cag − H. pylori infection dampens gastric inflammation due to cag + H. pylori infection
The activity and expression of MMP9 and 3 were upregulated with increased severity of gastric lesion
Cytokine expression pattern differed in different combination of H. pylori infection
To correlate the Th1 and Th17 cytokines responses in both gastric mucosa and spleen, the splenocytes from the infected mice were stimulated by H. pylori WCP in vitro for 48 h. Then, IFN-γ and IL-17A expression level in the supernatants of the cultured splenocytes were measured. Cytokines expression pattern in splenocytes match parallel with gastric tissues in H. pylori infected mice (Fig. 4b).
To confirm the involvement of Th1 response in H. pylori infection, we further measured the cytokine IL-12 that is responsible for the regulation of Th1 cell response. Our result showed that prior SS1 infection significantly upregulated IL-12 secretion as compared to cag − H. pylori infection both in gastric mucosa and spleen (Fig. 4a, b). Highest level of IL-12 was detected in SS1/SS1 infected group while AM1/AM1 exhibited lowest level. No significant difference in the expression of IL-12 was observed in between SS1/AM1 and AM1/SS1 infected groups.
Immunosuppression is mediated by cytokines IL-10 and TGF-β. Hence, we measured the level of IL-10 and TGF-β in H. pylori infected mouse gastric tissues. A significant decrease in the level of IL-10 and TGF-β were observed in the AM1/SS1 coinfected mice which correlate with reduced gastric inflammation (Fig. 4c).
Infiltration of Foxp3+ Treg cells in cag + strain infected gastric tissue was reduced by earlier cag − H. pylori infection
Interplay between inflammatory and immunosuppressive cytokines in H. pylori mediated gastric inflammation
We also measured the expression of Th17 cytokine IL-17A in different combination of H. pylori strain infected mice gastric tissues. Interestingly, we found that IL-17A expression increased in SS1/SS1 and SS1/AM1 infection, while no significant changes in IL-17A expression were observed in AM/AM1 infected group as compared to control. Surprisingly, AM1/SS1 infected group exhibited no significant increase in IL-17A expression as compared to control. We found a positive correlation between IL-17A expression and severity of gastric inflammation. Expression pattern of immunosuppressive cytokine TGF-β was also measured using Western blotting. Highest level of expression was detected in SS1/SS1 infected group. However, interestingly AM1/SS1 coinfected mice showed decreased TGF-β expression as compared to SS1/SS1 infected and SS1/AM1 coinfected groups. Furthermore, we did not found any significant change in TGF-β expression between AM1/SS1 and AM1/AM1 infected mice gastric tissues. The expression of TGF-β was higher in SS1/AM1 infected mice as compared to AM1/SS1 infected groups.
Helicobacter pylori colonization and associated pathology is determined by a combination of pathogen virulence factors and host immune response [5, 6, 38]. H. pylori infection induced a robust proinflammatory Th1 and Th17 response that are associated with gastric inflammation, atrophy, epithelial hyperplasia and dysplasia [10, 17, 18, 39]. Moreover, mixed or coinfection of different Helicobacter species/strains determined the outcome of disease severity. In this context, Secka et al. reported that mixed infection with cag + and cag − strains of H. pylori lowers disease burden among the Gambian population . Furthermore, coinfection with enterohepatic Helicobacter species can reduce H. pylori induced gastric pathology in C57BL/6 mice through modulation of gastric Th1 and Th17 responses . In present study we have investigated whether cag + and cag − H. pylori coinfection induces gastric mucosal inflammatory response differ from single strain infection. The study also focuses whether coinfection has any modulatory effect on gastric ulcer severity compared to single strain infection. We previously reported that both SS1 and AM1 strains were capable to cause gastric inflammation although the severity of damage was more pronounced in SS1 infection . Although, the functionality of SS1 cag gene within mouse gastric tissue is a controversial, but its association with severe gastric inflammation is well established. Our current result suggested that cag + strain (SS1) induced gastric pathology were significantly attenuated in mice that were earlier coinfected with cag − strain (AM1) and associated with modulation of Th17 and Treg cell responses.
It is reported that H. pylori infection is associated with elevated Th1 cytokines [10, 40]. Hence, we examined whether reduced gastric inflammation in AM1/SS1 coinfected mice has any correlation with Th1 cytokines level. We found that despite the reduced gastric inflammation pathology in AM1/SS1 infected mice, the expression of inflammatory Th1 cytokines IFN-γ, TNF-α and IL-1β in AM1/SS1 and SS1/AM1 are comparable (Fig. 5). Interestingly, significantly lower level of IL-17 was detected in AM1/SS1 coinfected group than SS1/AM1 coinfected group. Previous studies established the role of proinflammatory Th17 pathway in the development of H. pylori induced gastric inflammation in mouse model and human [39, 41]. Yun shi et al. suggested that both Th1 and Th17 cells mediated mucosal inflammation is important in H. pylori infection and Th17/IL-17 pathway modulates Th1 cell responses . Th17 cell responses are induced earlier than Th1 cell responses , implying that Th17 and Th1 cells promote inflammation differentially. It is known that active type IV secretion system is required for IL-17 secretion . We found that cag + strain infection induced IL-17A secretion in mouse gastric tissues as well as spleen, while cag − infection did not. It seems to us that severe gastric inflammation in SS1/SS1 infected mice were mediated by both Th1 and Th17 responses while AM1/AM1 infection only by Th1 responses. We found that the level of Th1 cytokines IFN-γ, TNF-α and IL-1β in AM1/SS1 infected mice are comparable to SS1/AM1infected mice. In contrast, higher level of IL-17A was detected in SS1/AM1 mice than AM1/SS1 infected mice. Thus our results clearly indicate that attenuated gastric pathology in AM1/SS1 infected group is not due to reduced Th1 responses instead of reduced Th17 responses to AM1/SS1 infection. We conclude that the Th1 cytokine induced by prior AM1 infection particularly IFN-γ could also contribute in part to the downregulation of Th17 response induced by subsequent cag + (SS1) infection because IFN-γ plays an inhibitory role towards Th17 cell activation [42, 43]. Thus, AM1 infection released high level of IFN- γ in the gastric lumen that prevented the activation of Th17 response resulting protection against further cag + infection.
Expression and secretion of different MMPs in H. pylori infection have been postulated to be critically involved in the development of gastric ulcer. However, recent evidences suggest that apart from its well studied inflammatory and pathogenic functions, MMPs play a more complex and diverse role in ECM homeostasis, regulation of inflammation, arresting disease progression . Role of cytokines and growth factors in regulation of MMPs expression have been reported earlier under various pathological conditions [22, 44]. IL-17 stimulated gastric epithelial cells to produce MMP9 and 3 that might be important in mediating gastric inflammation. However, a significantly lower level of MMP9 and 3 expressions were detected in AM1/SS1 coinfected mice compared to SS1 alone or SS1/AM1 coinfected group (Fig. 3). In line with our observation, it has been reported that MMP9 expression in the stomach following H. pylori infection was significantly reduced when IL-17 is deficient or blocked . Moreover, recombinant IL-17A treatment increased MMP9 expression in vitro . Our results show that the level of IL-17 is significantly increased only in the mouse gastric tissues infected with SS1 strains of H. pylori, suggesting that cag PAI is required for the induction of IL-17 cytokine, and also indicates that the cells producing MMPs have responded to the increased IL-17 secretions. Our results also suggested that the reduced gastritis in AM1/SS1 infected mice may be is due to reduced activation of Th17/IL-17 pathway and subsequent downregulation of MMP9 and 3 expressions in AM1/SS1 infected group.
It is well established that natural regulatory T (Foxp3+ Treg) cells suppress the host inflammatory responses during infection and thereby maintain physiological homeostasis of host immunity [45–47]. Elevated numbers of Treg cells were reported in H. pylori positive patients and H. pylori infected mice gastric tissues [48–50]. Moreover inhibition of Treg cells function by treatment with monoclonal antibody resulted increased expression of gastric proinflammatory cytokines that lead to severe gastritis in H. pylori infected mice . CD4+CD25+ Treg cells from H. pylori positive patients are more potent in the suppression of memory T cell responses . Treg mediated immune suppression is predominantly utilizes IL-10 and TGF-β that currently gain much attention [45, 46]. Previously it has been reported that H. pylori induced gastritis was suppressed by adoptive transfer of Treg cells harvested from IL-10-competent C57BL/6 donor mice, demonstrating that IL-10-dependent Treg cells play a crucial role in suppressing H. pylori-induced gastric disease . Our results also showed that the number of gastric foxp3+ cells as well as gastric IL-10 and TGF-β level were significantly higher in H. pylori infected mouse gastric tissues (Figs. 5, 6). While, AM1/SS1 infected mice with attenuated gastritis have fewer foxp3+ cells and lower level of gastric IL-10 and TGF-β. Hence we found a positive correlation between severity of gastritis and no of Foxp3+ cells as well as IL-10 and TGF-β expression. Previous reports suggested that IL-10 and TGF-β can suppress inflammatory Th17 as well as Th1 responses [53, 54]. So it is reasonable to postulate that prior AM1 infection creating an anti-inflammatory bias to further H. pylori infection at the outset of coinfection, with relatively lower demand for Treg cells at more chronic time points because the Th1 and Th17 response to subsequent H. pylori infection was suppressed by prior AM1 primed Treg cells.
We hypothesized that dendritic cells exposed to H. pylori may promote the preferential differentiation of naïve T cells into Treg cells. Those exposed dendritic cells then assist the differentiation of Treg cells as well as it lost its capability to further induce Th1 and Th17 responses upon subsequent H. pylori infection. Thus prior AM1 infected group showed reduced gastritis as its deficiency to induce Th17 response and probably stimulation of an anti-inflammatory bias by accumulation of AM1 sensitized dendritic and Treg cells within the gastric mucosa. In both SS1 and AM1 infection, primed Treg cells generated in gastric mucosa and these Treg cells provide protection against further infection of H. pylori by either directly or through cross reactivity. In contrast, prior SS1 infection cause an increase in the level of Th1 and Th17 responses are sufficient to do gastric damage. Irrespective of inhibitory role of SS1 primed Treg cells subsequent SS1 infection enjoy the benefit of existing inflammatory bias for further infection. However, earlier infection with AM1 helps in elicitation of AM1-primed Treg cells as well as less inflammatory bias through reduced secretion of Th1 cytokines. Subsequent infection of SS1 is prevented due to enrichment of AM1 primed Treg cells in the gastric mucosa that might provide protection through creating an anti inflammatory bias as well as by providing an un-hostile environment due to reduced inflammatory bias.
In summary, we suggest that existed cag − H. pylori infection attenuated severe gastric pathology induced by cag + H. pylori strain. Reduced gastric pathology is due to an anti-inflammatory bias created by cag − H. pylori. Further study is required to elucidate the cascade of interactions between H. pylori and mucosal cells, which will provide additional insights into the pathogenesis of H. pylori. A better understanding of the nature, regulation and function of the T-cells responses during H. pylori coinfection may help to design novel and cost effective strategies through which H. pylori induced gastric pathology might be controlled.
Culture of H. pylori strains
Two unrelated mouse adapted H. pylori strains with different genetic makeup were used: SS1 [34, 35], and AM1 (Indian strain) . SS1 (The Sydney Strain) is widely used as the standard mouse adapted strain for experimental infection. The strain AM1 was isolated from an endoscopic sample of an ulcer patient in Kolkata, India as mixed infections . Both strains of H. pylori were grown on brain–heart infusion agar (BHI; Difco Laboratories, Detroit, MI) supplemented with 7% sheep blood, 0.4% isovitalex and the antibiotics amphotericin B (8 µg/ml), trimethoprim (5 µg/ml) and vancomycin (8 µg/ml) (referred to here as BHI agar). The plates were incubated at 37 °C under 5% O2, 10% CO2 and 85% N2. In all experiments, overnight grown cultures on BHI agar plates were used.
Infection of C57BL/6 mice with H. pylori
Male C57BL/6 mice with free access to food and water were obtained from institutional animal house. Experiments were designed to minimize animal suffering and to use the minimum number to obtained valid statistical evaluation. Animal experiments were carried out according to the guidelines of animal ethics committee of the institute. Animals of both control and experimental groups were fasted for 6 h with free access to water. H. pylori infection in mice was done using a modification of the Kundu et al. method . Briefly, overnight grown bacterial cultures were harvested in 10 mM phosphate-buffered saline (PBS) and used for inoculation (108 CFU/mouse/inoculation). Mice were divided into five groups (n = 6 in each), first group serves as control was given PBS only. Among the rest 4 groups 2 groups were orogastrically inoculated twice in a period of three days with either AM1 (cag +) or SS1 (cag −) strain (AM1/AM1 and SS1/SS1) and the rest 2 groups were given criss-cross infection. Criss–cross means infection by cag + strain followed by cag − and vice versa (AM1/SS1 and SS1/AM1). Mice were sacrificed at day 10 after final inoculation (13 days post-primary inoculation).
Gastric tissues of control and 10-day infected mice were sectioned for histological studies. The tissue samples were fixed in 10% formalin and embedded in paraffin. The sections (5 µm) were cut using microtome, stained with hematoxylin and eosin , and assessed under an Olympus microscope. Images were captured using Camedia software (E-20P 5.0 Megapixel) at original magnification 10 × 10, 20 × 10 and 40 × 10 and processed in Adobe Photoshop version 7.0.
The pyloric part of the gastric mucosa of mice were suspended in PBS containing protease inhibitors, minced and incubated for 10 min at 4 °C. After incubation the suspension was centrifuged at 12,000×g for 15 min and the supernatant was collected as PBS extract. The pellet was extracted in the lysis buffer (10 mM Tris–HCl pH 8.0, 150 mM NaCl, and 1% Triton X-100 and protease inhibitors) and centrifuged at 12,000×g for 15 min to obtain TX extracts. Tissue extracts were preserved at −80 °C for future studies.
Blood samples were isolated from mouse by puncturing the heart followed by incubation for 30 min at room temperature. Serum was isolated from the clotted blood by low centrifugation. Serum sample was mixed with protease inhibitor mixture and stored at −80 °C. Equal volume of serum was used for gelatin zymography.
Gelatin and casein zymography
For assay of MMP2, 9 and 3 activities, tissue extracts were electrophoresed in 8% SDS–polyacrylamide gel containing 1 mg/ml gelatin or casein (sigma) respectively, under non-reducing conditions. Seventy micrograms proteins were loaded in each lane. The gels were washed twice in 2.5% Triton X-100 (Sigma) and then incubated either in calcium assay buffer or in stromelysin assay buffer at 37 °C. Gels were stained with 0.1% Coomassie blue followed by destaining . Quantification of zymographic-bands were done using Lab-Image software (Kapelan, Gmbh, Germany).
For assay of MMP9 activity in serum, mice serum samples were mixed with 1× nonreducing Laemmli sample loading buffer and were electrophoresed in SDS-8% polyacrylamide gel containing 1 mg/ml gelatin under nonreducing condition. Equal volume of serum samples were loaded in each lane. The gels were washed twice in 2.5% Triton X-100 and incubated in calcium assay buffer at 37 °C. Gels were then stained with 0.1% Coomassie Brilliant Blue stain followed by destaining. The zone of gelatinolytic activities appeared as negative staining. Quantification of zymographic bands were performed by densitometric analysis using Lab Image software (Kapelan Gmbh, Germany).
Measurement of cytokines by ELISA
Helicobacter pylori infected and uninfected mice gastric tissues were homogenized in 1 ml sterile PBS, and centrifuged. The supernatants were analyzed for IFN-γ, IL-12, IL-17, IL-10 and TGF-β using sandwich ELISA kits (eBioscience, San Diego, CA) according to the manufacturer’s instruction. Total protein was measured by the Lowry method. The cytokines concentrations in gastric tissue extracts were expressed as picograms per milligrams of total protein .
Splenocytes culture and cytokine measurement
Helicobacter pylori infected and uninfected mice spleens were passed through meshed steel sieve to obtain single-cell suspension of splenocytes. Splenocytes (1.6 × 106 cells/ml) were cultured in RPMI 1640 medium with or without H. pylori whole cell protein (WCP) (2.5 μg/ml).The production of IFN-γ, IL-12 and IL-17 in the supernatants was measured by sandwich ELISA (eBioscience, San Diego, CA) after 48 h of splenocytes culture .
For Immunofluorescence study, the tissue samples were fixed in 4% paraformaldehyde solution for 48 h, dehydrated in ascending alcohol series . It was embedded in paraffin wax and sectioned at 5 mm thickness using a microtome. The sections were deparaffinized with xylene followed by rehydration with descending alcohol series. Antigen retrieval was performed by trypsin (0.05% trypsin, 0.1% CaCl2) and blocking was performed using 5% BSA in TBS (20 mM Tris–HCl, pH 7.4 containing 150 mM NaCl) for 2 h at room temperature followed by the incubation over night at 4 °C in primary antibody solution (1:200 dilutions in TBS with 1% BSA) in a humid chamber. The tissue sections were washed four times with TBST (20 mM Tris HCl, pH 7.4 containing 150 mM NaCl and 0.025% Triton X-100) followed by incubation with fluorescein isothiocyanate and Texas Red-conjugated secondary antibody (Santa Cruz Biotechnology) solution. Then the tissue sections were washed four times with TBST followed by nuclear staining with DAPI. The images were observed in confocal microscopy. Images at X40 magnification were captured using Andor iQ 2.7 software (Andor spinning dise confocal microscope, Belfast, Ireland) and processed under Adobe Photoshop version 7.0 (Adobe Systems, San Jose, CA).
Tissue extracts (120 μg) were resolved by 10% reducing SDS–polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes . The membranes were blocked for 2 h at room temperature in 3% bovine serum albumin solution in 20 mM Tris–HCl, pH 7.4 containing 150 mM NaCl and 0.02% Tween 20 (TBST) followed by overnight incubation at 4 °C with 1:500 polyclonal anti-MMP9 (sc-6841, Santa Cruz Biotechnology), MMP3 (sc-6839, Santa Cruz Biotechnology), TNF-α (sc-1351, Santa Cruz Biotechnology), IL-1β (sc-7884, Santa Cruz Biotechnology), IL-17 (sc-374218, Santa Cruz Biotechnology), TGF-β (sc-7892, Santa Cruz Biotechnology,) and β-actin (4967S, cell signalling technology, MA, USA) antibodies. The membranes were washed four times with TBST and then incubated with their respective alkaline phosphatase-conjugated secondary antibody (Santa Cruz Biotechnology) (1:2000) for 1.5 h. The bands were visualized using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium substrate solution (Sigma).
Densitometry data are fitted using Sigma Plot. Data are presented as the mean ± SE. Statistical analysis was performed using the Student’s t test. P value less than 0.05 were considered as significant.
brain heart infusion agar
fetal bovine serum
tumor necrosis factor
transforming growth factor
SS and NG carried out study conception and design. NG, KK, PG carried out the experiments, participated in the analysis and interpretation of data and drafted the manuscript. AKM contributed to data analysis and edited the manuscript. All authors read and approved the final manuscript.
NK and KK acknowledge Council of Scientific and Industrial Research (CSIR) for providing fellowship.
The authors declare that they have no competing interests.
Availability of data and materials
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
Ethics approval and consent to participate
This study was carried out in strict accordance with the guidelines of Council of Scientific and Industrial Research, Government of India. The protocol was approved by the Animal Ethics Committee of Indian Institute of Chemical Biology affiliated to Indian Institute of Chemical Biology (a unit of Council of Scientific and Industrial Research), Kolkata. All experiments were performed under standard controlled conditions and all efforts were made to minimize animal suffering.
This study was supported by grants of BSC 0119 of CSIR, India.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999;284(5418):1328–33.View ArticlePubMedGoogle Scholar
- Westblom TU, Bhatt BD. Diagnosis of Helicobacter pylori infection. Curr Top Microbiol Immunol. 1999;241:215–35.PubMedGoogle Scholar
- Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 1997;113(6):1983–91.View ArticlePubMedGoogle Scholar
- Marshall BJ. Helicobacter pylori. Am J Gastroenterol. 1994;89(8 Suppl):S116–28.PubMedGoogle Scholar
- Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA. 1993;90(12):5791–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55(10):2111–5.PubMedGoogle Scholar
- Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA. 1996;93(25):14648–53.View ArticlePubMedPubMed CentralGoogle Scholar
- Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Investig J Tech Methods Pathol. 1995;73(6):760–70.Google Scholar
- Cover TL, Blaser MJ. Helicobacter pylori factors associated with disease. Gastroenterology. 1999;117(1):257–61.View ArticlePubMedGoogle Scholar
- Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998;114(3):482–92.View ArticlePubMedGoogle Scholar
- Lundgren A, Trollmo C, Edebo A, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun. 2005;73(9):5612–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Ohnita K, Isomoto H, Honda S, Wada A, Wen CY, Nishi Y, Mizuta Y, Hirayama T, Kohno S. Helicobacter pylori strain-specific modulation of gastric inflammation in Mongolian gerbils. World J Gastroenterol. 2005;11(10):1549–53.View ArticlePubMedPubMed CentralGoogle Scholar
- Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun. 1998;66(12):5964–71.PubMedPubMed CentralGoogle Scholar
- Mizuno T, Ando T, Nobata K, Tsuzuki T, Maeda O, Watanabe O, Minami M, Ina K, Kusugami K, Peek RM, et al. Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J Gastroenterol. 2005;11(40):6305–11.View ArticlePubMedPubMed CentralGoogle Scholar
- Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42(5):963–70.View ArticlePubMedGoogle Scholar
- Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 2000;43(11):2455–63.View ArticlePubMedGoogle Scholar
- Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, Wu C, Mao XH, Jia KR, Wang FJ, et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol. 2010;184(9):5121–9.View ArticlePubMedGoogle Scholar
- Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, Lechler RI, Lombardi G. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun. 2010;78(2):845–53.View ArticlePubMedGoogle Scholar
- Aujla SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense. Semin Immunol. 2007;19(6):377–82.View ArticlePubMedPubMed CentralGoogle Scholar
- Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer. 2002;2(9):657–72.View ArticlePubMedGoogle Scholar
- Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005;280(10):9409–15.View ArticlePubMedGoogle Scholar
- Verma S, Kesh K, Ganguly N, Jana S, Swarnakar S. Matrix metalloproteinases and gastrointestinal cancers: impacts of dietary antioxidants. World J Biol Chem. 2014;5(3):355–76.View ArticlePubMedPubMed CentralGoogle Scholar
- Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827–39.View ArticlePubMedGoogle Scholar
- Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Bio Chem Hoppe Seyler. 1995;376(6):345–55.Google Scholar
- Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14(7):455–63.View ArticlePubMedGoogle Scholar
- Kundu P, Mukhopadhyay AK, Patra R, Banerjee A, Berg DE, Swarnakar S. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem. 2006;281(45):34651–62.View ArticlePubMedGoogle Scholar
- Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292(5519):1115–8.View ArticlePubMedGoogle Scholar
- Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, Nagler-Anderson C. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med. 2000;6(5):536–42.View ArticlePubMedGoogle Scholar
- Higgins PD, Johnson LA, Luther J, Zhang M, Sauder KL, Blanco LP, Kao JY. Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis. 2011;17(6):1398–408.View ArticlePubMedGoogle Scholar
- Ge Z, Feng Y, Muthupalani S, Eurell LL, Taylor NS, Whary MT, Fox JG. Coinfection with enterohepatic Helicobacter species can ameliorate or promote Helicobacter pylori-induced gastric pathology in C57BL/6 mice. Infect Immun. 2011;79(10):3861–71.View ArticlePubMedPubMed CentralGoogle Scholar
- Secka O, Antonio M, Berg DE, Tapgun M, Bottomley C, Thomas V, Walton R, Corrah T, Thomas JE, Adegbola RA. Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia. PLoS ONE. 2011;6(11):e27954.View ArticlePubMedPubMed CentralGoogle Scholar
- Campbell DI, Warren BF, Thomas JE, Figura N, Telford JL, Sullivan PB. The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children. Helicobacter. 2001;6(4):263–7.View ArticlePubMedGoogle Scholar
- Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33(4):429–31.View ArticlePubMedPubMed CentralGoogle Scholar
- Lee A, O’Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 1997;112(4):1386–97.View ArticlePubMedGoogle Scholar
- Nolan KJ, McGee DJ, Mitchell HM, Kolesnikow T, Harro JM, O’Rourke J, Wilson JE, Danon SJ, Moss ND, Mobley HL, et al. In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun. 2002;70(2):685–91.View ArticlePubMedPubMed CentralGoogle Scholar
- Kesh K, Subramanian L, Ghosh N, Gupta V, Gupta A, Bhattacharya S, Mahapatra NR, Swarnakar S. Association of MMP7-181A → G promoter polymorphism with gastric cancer risk: influence of nicotine in differential allele-specific transcription via increased phosphorylation of cAMP-response element-binding protein (CREB). J Biol Chem. 2015;290(23):14391–406.View ArticlePubMedPubMed CentralGoogle Scholar
- Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76(9):4350–4.View ArticlePubMedPubMed CentralGoogle Scholar
- Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113(3):321–33.View ArticlePubMedPubMed CentralGoogle Scholar
- Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, Imeneo M, Pallone F. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol. 2000;165(9):5332–7.View ArticlePubMedGoogle Scholar
- Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol. 2000;165(2):1022–9.View ArticlePubMedGoogle Scholar
- Shiomi S, Toriie A, Imamura S, Konishi H, Mitsufuji S, Iwakura Y, Yamaoka Y, Ota H, Yamamoto T, Imanishi J, et al. IL-17 is Involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter. 2008;13(6):518–24.View ArticlePubMedPubMed CentralGoogle Scholar
- Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123–32.View ArticlePubMedGoogle Scholar
- Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Investig. 2004;114(9):1198–208.View ArticlePubMedPubMed CentralGoogle Scholar
- Löffek S, Schilling O, Franzke CW. Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2011;38(1):191.View ArticlePubMedGoogle Scholar
- Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol. 2009;21(10):1105–11.View ArticlePubMedGoogle Scholar
- Sojka DK, Huang Y-H, Fowell DJ. Mechanisms of regulatory T-cell suppression—a diverse arsenal for a moving target. Immunology. 2008;124(1):13–22.View ArticlePubMedPubMed CentralGoogle Scholar
- Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol. 2007;7(11):875–88.View ArticlePubMedGoogle Scholar
- Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology. 2006;131(2):525–37.View ArticlePubMedGoogle Scholar
- Liu S, Luo J, Liu Y, Tang S, Chen C, Cai H, Yu M, Zhang Y. CD4(+) Foxp3(+) regulatory T-cell number increases in the gastric tissue of C57BL/6 mice infected with Helicobacter pylori. APMIS. 2015;123(7):571–9.View ArticlePubMedGoogle Scholar
- Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Peña A, Rollán A, Viviani P, Guiraldes E, et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology. 2008;134(2):491–9.View ArticlePubMedGoogle Scholar
- Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun. 2003;71(4):1755–62.View ArticlePubMedPubMed CentralGoogle Scholar
- Lee CW, Rao VP, Rogers AB, Ge Z, Erdman SE, Whary MT, Fox JG. Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2−/− mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun. 2007;75(6):2699–707.View ArticlePubMedPubMed CentralGoogle Scholar
- Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013;11(6):385–99.View ArticlePubMedPubMed CentralGoogle Scholar
- Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol. 2009;183(3):1577–86.View ArticlePubMedGoogle Scholar